{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:58:33Z","timestamp":1781632713234,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kafr El Shiekh University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preeclampsia is a hypertensive disorder of pregnancy associated with significant maternal and neonatal morbidity and mortality. Osteoprotegerin (OPG), a glycoprotein involved in vascular homeostasis, has emerged as a potential biomarker for disease severity. This study aimed to evaluate serum OPG levels in pregnant women with and without late-onset preeclampsia and to assess its correlation with disease severity and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This case\u2013control study was conducted at Ain Shams University Maternity Hospital between August 2022 and January 2024. Ninety pregnant women with gestational age\u2009\u2265\u200934 weeks were enrolled and equally divided into three groups: normotensive controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200930), mild late-onset preeclampsia (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200930), and severe late-onset preeclampsia (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200930). Clinical assessments, laboratory investigations, and serum OPG levels (measured by ELISA) were compared among groups. Correlation, multivariate regression, and receiver operating characteristic (ROC) curve analyses were performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Serum OPG levels were significantly higher in women with late-onset preeclampsia, particularly in the severe group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Elevated OPG levels were strongly correlated with adverse perinatal outcomes, including fetal growth restriction, preterm delivery, NICU admission, and cesarean delivery. Multivariate regression analysis demonstrated that OPG levels were independently associated with preeclampsia severity and adverse perinatal outcomes. ROC analysis showed excellent diagnostic performance of OPG in identifying severe late-onset preeclampsia (AUC\u2009=\u20090.976), with sensitivity and specificity of 93.3%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum OPG levels are significantly elevated in late-onset preeclampsia and correlate closely with disease severity and adverse maternal and fetal outcomes. OPG shows promise as a clinical biomarker for identifying severe late-onset preeclampsia, although its utility in mild disease appears limited.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-08638-9","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T23:25:10Z","timestamp":1769988310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum osteoprotegerin levels and their association with preeclampsia severity: a case-control study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ahmed Mohammed Essam","family":"El Din Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ramy Mohamed","family":"Ramy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan Mahmoud Mohamed","family":"Metwaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ramadan Abd","family":"El Latif El Deep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2747-3353","authenticated-orcid":false,"given":"Ahmed Nagy","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Ahmed","family":"Ebeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Saeed","family":"Khallaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"suppl1","key":"8638_CR1","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1111\/nure.12055","volume":"71","author":"A -Jeyabalan","year":"2013","unstructured":"Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013;71(suppl1):S18\u201325.","journal-title":"Nutr Rev"},{"issue":"2","key":"8638_CR2","doi-asserted-by":"publisher","first-page":"S786","DOI":"10.1016\/j.ajog.2021.12.001","volume":"226","author":"O -Erez","year":"2022","unstructured":"Erez O, Romero R, Jung E, Chaemsaithong P, Bosco M, Suksai M, Gallo DM, Gotsch F. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol. 2022;226(2):S786\u2013803.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"8638_CR3","first-page":"e1","volume":"133","author":"-American College of Obstetricians and Gynecologists","year":"2019","unstructured":"American College of Obstetricians and Gynecologists. ACOG practice bulletin 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):e1\u201325.","journal-title":"Obstet Gynecol"},{"issue":"14","key":"8638_CR4","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.3390\/ijms25147569","volume":"25","author":"J -Torres-Torres","year":"2024","unstructured":"Torres-Torres J, Espino-y-Sosa S, Martinez-Portilla R, Borboa-Olivares H, Estrada-Gutierrez G, Acevedo-Gallegos S, Ruiz-Ramirez E, Velasco-Espin M, Cerda-Flores P, Ramirez-Gonzalez A, Rojas-Zepeda L. A narrative review on the pathophysiology of preeclampsia. Int J Mol Sci. 2024;25(14):7569.","journal-title":"Int J Mol Sci"},{"key":"8638_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.earlhumdev.2019.06.001","volume":"135","author":"N -Oikonomou","year":"2019","unstructured":"Oikonomou N, Papadopoulou C, Fouzas S, Kritikou D, Chrysis D, Sinopidis X, Dimitriou G, Karatza AA. Osteoprotegerin and RANKL serum concentrations in neonates of mothers with early-onset pre-eclampsia: comparison with neonates of normotensive mothers. Early Hum Dev. 2019;135:1\u20135.","journal-title":"Early Hum Dev"},{"issue":"4","key":"8638_CR6","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s10741-021-10153-2","volume":"27","author":"M -Dutka","year":"2022","unstructured":"Dutka M, Bobi\u0144ski R, Wojakowski W, Francuz T, Paj\u0105k C, Zimmer K. Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases. Heart Fail Rev. 2022;27(4):1395\u2013411.","journal-title":"Heart Fail Rev"},{"key":"8638_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s42358-024-00384-w","volume":"64","author":"CD -Duran","year":"2024","unstructured":"Duran CD, Caparbo VD, Santiago MB, Hounkpe BW, Pedreira AL, Lima IV, Giardini HA, Bonoldi VL, Domiciano DS, Shinjo SK, Pereira RM. Serum osteoprotegerin and its gene polymorphisms in patients with takayasu\u2019s arteritis: a bicentric cross-sectional study. Adv Rheumatol. 2024;64:43.","journal-title":"Adv Rheumatol"},{"issue":"8","key":"8638_CR8","doi-asserted-by":"publisher","first-page":"e44340","DOI":"10.1371\/journal.pone.0044340","volume":"7","author":"P -Shen","year":"2012","unstructured":"Shen P, Gong Y, Wang T, Chen Y, Jia J, Ni S, Zhou B, Song Y, Zhang L, Zhou R. Expression of osteoprotegerin in placenta and its association with preeclampsia. PLoS ONE. 2012;7(8):e44340. https:\/\/doi.org\/10.1371\/journal.pone.0044340. Epub 2012 Aug 30. PMID: 22952959; PMCID: PMC3431377.","journal-title":"PLoS ONE"},{"issue":"1","key":"8638_CR9","doi-asserted-by":"publisher","first-page":"5581570","DOI":"10.1155\/2021\/5581570","volume":"2021","author":"WN -Phoswa","year":"2021","unstructured":"Phoswa WN, Khaliq OP. The role of oxidative stress in hypertensive disorders of pregnancy (preeclampsia, gestational hypertension) and metabolic disorder of pregnancy (gestational diabetes mellitus). Oxidative Med Cell Longev. 2021;2021(1):5581570.","journal-title":"Oxidative Med Cell Longev"},{"issue":"14","key":"8638_CR10","doi-asserted-by":"publisher","first-page":"7886","DOI":"10.3390\/ijms25147886","volume":"25","author":"A -Gusella","year":"2024","unstructured":"Gusella A, Martignoni G, Giacometti C. Behind the curtain of abnormal placentation in Pre-eclampsia: from molecular mechanisms to histological hallmarks. Int J Mol Sci. 2024;25(14):7886.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"8638_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00223-019-00573-6","volume":"105","author":"L -Rochette","year":"2019","unstructured":"Rochette L, Meloux A, Rigal E, Zeller M, Malka G, Cottin Y, Vergely C. The role of osteoprotegerin in vascular calcification and bone metabolism: the basis for developing new therapeutics. Calcif Tissue Int. 2019;105(3):239\u201351.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"8638_CR12","first-page":"159","volume":"299","author":"-ACOG practice bulletin","year":"2002","unstructured":"ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;299(1):159\u201367.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"8638_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/1735-1995.193170","volume":"21","author":"H -Chen","year":"2016","unstructured":"Chen H, Tao F, Fang X, Wang X. Association of hypoproteinemia in preeclampsia with maternal and perinatal outcomes: A retrospective analysis of high-risk women. J Res Med Sci. 2016;21(1):98.","journal-title":"J Res Med Sci"},{"issue":"5","key":"8638_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1017\/S2040174411000511","volume":"2","author":"B -Essley","year":"2011","unstructured":"Essley B, McNanley T, Cooper B, McIntyre A, Witter F, Harris Z, O\u2019Brien K. Osteoprotegerin in pregnant adolescents differs by race and is related to infant birth weight z-score. J Dev Origins Health Disease. 2011;2(5):272\u20139.","journal-title":"J Dev Origins Health Disease"},{"issue":"5","key":"8638_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2174\/1570161117666191022095246","volume":"18","author":"K -Maniatis","year":"2020","unstructured":"Maniatis K, Siasos G, Oikonomou E, Vavuranakis M, Zaromytidou M, Mourouzis K, Paraskevopoulos T, Charalambous G, Papavassiliou AG, Tousoulis D. Osteoprotegerin and osteopontin serum levels are associated with vascular function and inflammation in coronary artery disease patients. Curr Vasc Pharmacol. 2020;18(5):523\u201330.","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"8638_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12884-025-07444-z","volume":"25","author":"P -Rashidian","year":"2025","unstructured":"Rashidian P, Parsaei M, Hantoushzadeh S, Salmanian B. Investigating the association of albuminuria with the incidence of preeclampsia and its predictive capabilities: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2025;25(1):322.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"7","key":"8638_CR17","doi-asserted-by":"publisher","first-page":"e2420382","DOI":"10.1001\/jamanetworkopen.2024.20382","volume":"7","author":"J -Check","year":"2024","unstructured":"Check J, Shuster C, Hofheimer J, Camerota M, Dansereau LM, Smith LM, Carter BS, DellaGrotta SA, Helderman J, Kilbride H, Loncar CM. Preeclampsia, fetal growth restriction, and 24-month neurodevelopment in very preterm infants. JAMA Netw Open. 2024;7(7):e2420382.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"8638_CR18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ajog.2005.06.051","volume":"193","author":"JS -Hong","year":"2005","unstructured":"Hong JS, Santolaya-Forgas J, Romero R, Espinoza J, Gon\u00e7alves LF, Kim YM, Edwin S, Yoon BH, Nien JK, Hassan S, Mazor M. Maternal plasma osteoprotegerin concentration in normal pregnancy. Am J Obstet Gynecol. 2005;193(3):1011\u20135.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"8638_CR19","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1210\/jc.2003-030486","volume":"88","author":"KE -Naylor","year":"2003","unstructured":"Naylor KE, Rogers A, Fraser RB, Hall V, Eastell R, Blumsohn A. Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. J Clin Endocrinol Metabolism. 2003;88(11):5361\u20135.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"8638_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.clinbiochem.2004.10.013","volume":"38","author":"E -D\u00edaz","year":"2005","unstructured":"D\u00edaz E, C\u00e1rdenas M, Ariza AC, Larrea F, Halhali A. Placental insulin and insulin-like growth factor I receptors in normal and preeclamptic pregnancies. Clin Biochem. 2005;38(3):243\u20137.","journal-title":"Clin Biochem"},{"issue":"2","key":"8638_CR21","first-page":"90","volume":"43","author":"F -Ming","year":"2008","unstructured":"Ming F, Zhou R, Cheng WB, Tie WW. Study of adiponectin expression in placenta and its correlation with preeclampsia. Zhonghua Fu Chan Ke Za Zhi. 2008;43(2):90\u20133.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-08638-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08638-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-08638-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:29:59Z","timestamp":1781630999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-08638-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8638"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-08638-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The protocol was reviewed and approved by the Scientific and Ethics Committee of the OBGYN department, Ain Shams University, under protocol number (MS\/396\/2022) on [26-7-2022]. Informed consent was obtained from all participants included in the study. Participants were provided with detailed information about the study objectives, procedures, potential risks and benefits, confidentiality measures, and their right to withdraw at any time without consequences. Written consent was obtained from each participant before their inclusion in the study. Additionally, participants\u2019 confidentiality was strictly maintained throughout the research process, and all data were anonymized to ensure privacy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No individual or identifiable patient data are included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}